Laura Jelliffe-Pawlowski

Laura Jelliffe-Pawlowski is the Co-Founder and CEO of EGG Health Pregnancy, a tech startup providing pregnant women and new parents with personalized health data. She is also the Chief of the Division of Lifecourse Epidemiology and a Professor of Epidemiology & Biostatistics and of Global Health Sciences at the University of California San Francisco (UCSF) School of Medicine; the Director of Precision Health and Discovery with the UCSF California Preterm Birth Initiative; the Lead and Founder of the UCSF HOPE Research Consortium; and the Primary Investigator of the HOPE COVID-19 Study, which investigates the impact of the pandemic on pregnant women and infants.

Throughout her professional roles, Dr. Jelliffe-Pawlowski's work focuses on uncovering the causes of adverse pregnancy and infant outcomes, and identifying interventions through the development of novel tools and tests applicable globally. Her research has received funding from prestigious sources such as the National Institutes of Health, the Bill & Melinda Gates Foundation, and the March of Dimes.

She has authored over 150 scientific papers on pregnancy and infant health and holds patents for blood tests and algorithms predicting preterm birth, preeclampsia, and mortality/morbidity in preterm infants. Dr. Jelliffe-Pawlowski's work has been featured in various media outlets, including the New York Times, the Atlantic, WIRED Magazine, CNN, NPR, BBC, the "Today Show," "CBS Evening News," and many others; Forbes named her to their "50 Over 50" list in 2023.

Dr. Jelliffe-Pawlowski has served as an adviser on state, national, and international committees and task forces dedicated to the early detection and prevention of preterm birth and developmental disabilities. She possesses extensive expertise in researching racial/ethnic and socioeconomic disparities in adverse pregnancy and infant outcomes.